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Bangladesh has experienced a variety of diseases caused by natural dissemination of an array of path-
ogenic microorganisms into the environment. While cures for these diseases largely depend on the
medication strategies of physicians, determining the reasons for disease persistence as well for the onset
of reinfection is also essential. Routine diagnosis of common diseases usually means treatment with a
range of appropriate medicines; however, failure of these medications because of the drug resistance of
microorganisms accompanied by a lack of alertness about the etiology of diseases often leads to fatal
results. The present review reports on emerging diseases in Bangladesh and focuses on associated
microbiological research into ongoing diseases including enteric, urinary tract, and malarial complica-
tions. The viruses associated with acquired immunodeﬁciency syndrome and hepatitis are also discussed.
Copyright © 2015, Buddhist Compassion Relief Tzu Chi Foundation. Published by Elsevier Taiwan LLC. All
rights reserved.1. Introduction
Infectious diseases are a pervasive menace worldwide. The
incidence and prevalence as well as the emergence and re-
emergence of a particular disease depend on the geographical
and economic background [1e4]. Althoughmost emerging diseases
are conquered by new-generation chemotherapeutic agents, some
complications remain uncontrolled and hence tend to spread
rapidly as little is known about their etiology and subsequent
management [1,2,5e9]. New and re-emerging infectious diseases
such as severe acute respiratory syndrome, pneumonia, inﬂuenza,
swine ﬂu (H1N1), tuberculosis (TB), hepatitis, malaria, cholera,
chikungunya, meningitis, Ebola virus diseases, food-borne gastro-
enteritis, salmonellosis, and campylobacteriosis continue to
threaten global public health [2,5,10e24].
Major challenges in disease management have evolved as drug-
resistant bacteria have emerged, posing a signiﬁcant impact on the
efﬁciency of chemotherapy [25]. During the past few years, the
antibacterial activity of a number of drugs has decreased with theiology, Stamford University
Bangladesh. Tel.: þ880 2
.
elief Tzu Chi Foundation. Publisheconcomitant onset of the drug-resistant pathogenic bacteria
[6,25e27]. This has become one the most severe public health is-
sues worldwide, leading to fatalities from simple microbial in-
fections followed by treatment-mediated complications from
inactive drugs [25]. The worldwide increases in single drug-
resistant bacteria, multidrug-resistant (MDR) bacteria, and exten-
sively drug-resistant (XDR) bacteria are indeed well-known
[26,28e37]. Incidences of methicillin-resistant Staphylococcus
aureus (MRSA), vancomycin-resistant S. aureus (VRSA), coagulase-
negative staphylococci, glycopeptides intermediate-sensitive
S. aureus, vancomycin-resistant Enterococcus species, penicillin-
resistant Streptococcus pneumoniae, extended-spectrum b-lacta-
mase (ESBL)-producing bacteria, and carbapenem-resistant bacte-
ria, especially in developing countries, have also been noted
[6,26,38e45]. Bangladeshi people commonly consume large
quantities of antibiotics not prescribed by physicians. Similar abuse
of antibiotic agents also occurs frequently in India and Pakistan
[25,46]. By contrast, in the United States and Europe, the levels of
resistance of bacterial pathogens against antibiotics are lower
because of stringency in prescription [46].
A variety of microorganisms triggering enteric diseases along
with diseases such as cancer, respiratory and pulmonary infections,
inﬂuenza, heart diseases, malaria, TB, dengue, liver cirrhosis, uri-
nary tract infections (UTIs), diabetes, chikungunya, and opportu-
nistic infections pose major public health-related complications ind by Elsevier Taiwan LLC. All rights reserved.
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[2,8,28,30,32,47e60]. The high-density population, lack of aware-
ness of personal hygiene, inadequate microbiological processing of
food and pharmaceuticals, defective water-distribution systems
saturated with sewage pipelines, and above all the ineffectiveness
of antimicrobial agents have been known to account for the onset of
these diseases [25,26,61e66]. Hospital-acquired infections and
drug-resistant infecting pathogens complicate treatment outcomes
[25,26,48].
For the past 10 years, scientists and academicians, together with
their international collaborators, have made efforts to understand
many of the pathogenic mechanisms of emerging and re-emerging
infectious diseases, to discover novel diagnostic methods with
appropriate antiviral, antibacterial, and antifungal compounds and
to develop vaccines [2,67,68]. For more than four decades, the
Centers for Disease Control and Prevention in Bangladesh has
collaborated with the International Centre for Diarrheal Disease
Research, Bangladesh to mitigate health-related problems and
strengthen the country's capacity to diagnose and detect emerging
infectious diseases [47]. In addition, microbiological experiments
are being conducted to identify etiological agents and ﬁnd accurate
remedies [8,28,30,32,49,52,53,58e60].
2. Microbiological studies of emerging diseases in Bangladesh
In vitro microbiological studies of different diseases in
Bangladesh have revealed the growth and proliferation of a large
number of bacterial pathogens. Microbiological studies havemostly
been carried out using conventional differential and selective cul-
ture media, morphological tests, conﬁrmative biochemical identi-
ﬁcation, antibiogram assays, and tests for ESBL and carbapenemase
production as described earlier [69e73]. In most cases, a huge
bacterial onset with an alarming threat of MDR would suggest the
appropriate bactericidal action together with the effective thera-
peutic events.
2.1. Microorganisms associated with enteric diseases
Commencement of enteric diseases (e.g., cholera, diarrhea,
dysentery) in the developing countries principally occurs because
of microbiologically contaminated food and water associated with
an unhygienic lifestyle [61e63]. The global cholera burden has been
estimated to be 3e5 million cases and accounts for a total of
100,000e130,000 deaths annually [74]. Bangladesh is at a very high
risk of cholera [61,75,76]. A study conducted by Acharjee et al [61]
quantiﬁed signiﬁcant Vibrio spp. in meat, ﬁsh, vegetables, fruits,
street food, bakery shop foods, fast food, sweets, and dairy prod-
ucts. Their drug-resistant traits pose a serious public health hazard.
Hossain et al [55] estimated that the prevalences of bacteria other
than Vibrio cholerae causing diarrhea in children were 2% for Yer-
sinia spp., Aeromonas spp., and Plesiomonas spp., 6% for Vibrio spp.,
10% for Salmonella spp. and Shigella spp., and 14% for Campylobacter
spp.
2.2. Opportunistic pathogens and intestinal parasites associated
with human immunodeﬁciency virus
The interactions between human immunodeﬁciency virus (HIV)
and opportunistic pathogenic bacteria and other intestinal para-
sites arewell-known, and they inﬂuence the health status of people
with HIV/acquired immunodeﬁciency syndrome. Noor et al [8]
conducted a study to detect enteric parasites in HIV-infected pa-
tients with enteric diseases. Intestinal parasitic pathogens were
found in around 77% of patients with HIV, which were also asso-
ciated with the growth and proliferation of opportunisticpathogens. These included Cryptosporidium spp., Blastocystis hom-
inis, Entamoeba histolytica, Hymenolepis nana, Isospora belli, Giardia
lamblia, Cyclospora species, Ascaris lumbricoides, and Trichuris tri-
chiura. Cryptosporidium spp. were found to be prominent in HIV-
positive patients suffering from diarrhea, and polyparasitic in-
fections were demonstrated in chronic cases with low CD4 counts.
Noor et al [49] noted that common opportunistic infections asso-
ciated with HIV included diarrhea, pulmonary TB, gland TB, skin
lesions, and fever. Other problems associated with HIV mainly
include respiratory and gastrointestinal tract complications, bron-
chitis, UTIs, sexually transmitted diseases, weight loss, pharyngitis,
prostatitis, skin rashes, and oral ulcerations. However, the HIV
prevalence rate in Bangladesh is still estimated to be very low
[8,49].
2.3. Microorganisms associated with burn wounds
A major fraction of burn wound samples was found to harbor
total aerobic viable bacteria up to 107 colony-forming units/mL. The
predominant pathogens were Pseudomonas spp., S. aureus, and
Klebsiella spp. followed by Enterobacter spp. and Escherichia coli.
Most of the pathogens were found to be drug resistant and several
isolates were noted to be MDR [26].
2.4. Drug-resistant TB in Bangladesh
TB, principally caused by Mycobacterium tuberculosis, is a major
health problem globally [28,74,77e80]. In Bangladesh, there are >
350,000 new cases with 70,000 deaths annually [30,32,57,60].
Cases of MDR and XDR TB in Bangladesh are of extreme signiﬁcance
in overall public health management [28,32,81]. In addition to TB,
MDR bacteria can result in various clinical complications followed
by treatment failure when employing antibiotics [25,62,65]. A
clinical investigation in Bangladesh revealed that > 70% of infecting
bacteria were resistant to at least one of the commonly used anti-
biotics [25]. MDR bacteria including MRSA, methicillin-resistant
Staphylococcus epidermidis, VRSA, methicillin-resistant coagulase-
negative staphylococci, and penicillin-resistant S. pneumoniae are
widely known to be difﬁcult to eradicate [6,7,25,26,31,37,45,46,71].
2.5. Hepatitis B virus infection
Hepatitis B, an infectious illness caused by hepatitis B virus
(HBV) is responsible for chronic hepatitis, liver cirrhosis, and he-
patocellular carcinoma, ultimately causing death [50]. Approxi-
mately 2 billion people have been reported to be infected with the
HBVworldwide [50,54,58]. In Bangladesh, HBV infections can occur
because of a lack of health education and vaccination [54]. Studies
of HBV include the following: (1) detection of biochemical and
serological markers of HBV infection other than HBsAg, (2)
uncovering common risk factors associated with HBsAg positivity
among patients suspected to have HBV infection, and (3) investi-
gating the efﬁcacy of vaccines for hepatitis B to reveal the immu-
nological memory against the vaccine [50,54,58]. Detecting the
serum HBV DNA level has proven to be comparatively effective in
assessing liver disease activity [50,54].
2.6. Carbapenemase-producing Klebsiella pneumoniae and
microorganisms associated with UTI
The resistance of Klebsiella pneumoniae against carbapenem is
another rising global health issue [82,83]. Hayder et al [7] studied
carbapenemase-producing K. pneumoniae in Dhaka, Bangladesh. A
total of 647 K. pneumoniae isolates were found in 2800 patients
with UTIs, bacteremia, wound infections, and respiratory diseases.
R. Noor, Md.S. Munna / Tzu Chi Medical Journal 27 (2015) 49e53 51Thirty-one carbapenem-resistant isolates were found to harbor
K. pneumoniae carbapenemase. An additional 287 isolates were
ESBL positive [7]. Indeed, K. pneumoniae are the most predominant
genera carrying ESBLs and are usually highly resistant to amino-
glycosides, ﬂuoroquinolones, and sulfonamides [84].
Carbapenemase-producing E. coli strains are also well-known
[85,86]. From 2007 to 2011, 22 E. coli strains producing
K. pneumoniae carbapenemase were isolated in Hangzhou, China.
Twelve of these were isolated in 2011, suggesting an escalation in
carbapenem-resistant E. coli in China [85]. A recent study con-
ducted by Peirano et al [86] showed that 407 of 47,843 E. coli iso-
lates had b-lactamase genes and 116 of the 407 isolates were
positive for an array of carbapenemases.
UTI is a common clinical complication worldwide [87,88] with a
high incidence in Bangladesh [6]. A study conducted by Noor et al
[51] revealed that among 462 urine samples collected from patients
with UTI, 100 were found to be culture positive. E. coli was the
predominant organism, whereas Klebsiella and Enterococcus were
also prevalent. Other bacteria isolated included Pseudomonas spp.
and Proteus spp. An interesting aspect of ESBL production was
noted in a study of UTI patients by Khan et al [6]. ESBL-producing
microorganisms are known to exhibit important therapeutic
complications as they develop resistance against third-generation
antibiotics. In a previous study, E. coli was found to show stronger
resistance against several antibiotics than isolates tested in Europe
[89].
2.7. Microorganisms associated with malaria
Malaria is another prevailing public health issue in Bangladesh.
The major microorganisms associated with malarial disease are
Plasmodium falciparum and Plasmodium vivax. The former causes
around 90% of malaria in Bangladesh [59]. The global impact of
malaria has drawn interest in developing an effective diagnosis,
especially in resource-poor settings. Jahan et al [59] conducted
experiments on rapid diagnostic tests for malaria and endorsed the
OnSite test based on antigen detection over the SD Bioline anti-Pf/Pv
test based on antibody detection. However, both methods can
detect multiple infections (caused by different species of Plasmo-
dium) with a higher sensitivity and speciﬁcity than conventional
microscopy. Therefore, these methods are expected to aid in the
National Malaria Control Program.
3. Addressing the problem of emerging diseases in
Bangladesh: Recommendations
In Bangladesh, the majority of people maintain a poor quality of
life and have a meager education. Knowledge about the generation
and subsequent spread of diseases is very scanty [2]. The ﬁrst step
to minimize emerging infections is to increase public awareness of
hygiene. Knowledge about unhygienic handling of water and food
is of signiﬁcance [61,62]. Appropriate therapy with physician's
recommendations can minimize treatment complications [6,25].
These actions could be regulated by governmental bodies
employing health professionals. Another important clinical aspect
is the study of neglected tropical diseases (NTDs), which are known
to cover a wide range of infections predominantly affecting the
poorest and most vulnerable individuals. In Bangladesh, these
include lymphatic ﬁlariasis, trachoma, soil-transmitted helminths,
leprosy, guinea worms, and visceral leishmaniasis [90].
4. Conclusion
Currently in Bangladesh, both governmental and nongovern-
mental organizations are working to eradicate health-associatedproblems in the community. However, more emphasis should
be given to conducting ﬁeld and laboratory research on diseases
of public health importance. Attention should be drawn to
emerging diseases, such as respiratory complications, zoonotic
diseases, vector-borne diseases, and NTDs, as well as other
identiﬁed public health priorities. The research outcomes should
be evaluated to enhance the overall management of disease
prevention and control programs. Training and capacity building
programs for health improvement are also important to minimize
emerging diseases. Emphasis should be given to sharing of
expertise and research ﬁndings with other nations as well as
academic and research organizations. Finally, to successfully
combat disease-causing microbial ﬂora, pioneering microbiolog-
ical research on the principal mechanisms underlying microbial
pathogenesis both at the initiating stage and during disease
progression is essential.
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